Identification of multicohort-based predictive signature for NMIBC recurrence reveals SDCBP as a novel oncogene in bladder cancer
Background Despite surgical and intravesical chemotherapy interventions, non-muscle invasive bladder cancer (NMIBC) poses a high risk of recurrence, which significantly impacts patient survival. Traditional clinical characteristics alone are inadequate for accurately assessing the risk of NMIBC recu...
Saved in:
Main Authors: | Chen Zhang, Hubin Yin, Tinghao Li, Junrui Chen, Weiyang He, Ke Ren, Bo Li, Xudong Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2025-12-01
|
Series: | Annals of Medicine |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/07853890.2025.2458211 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
AI predicting recurrence in non-muscle-invasive bladder cancer: systematic review with study strengths and weaknesses
by: Saram Abbas, et al.
Published: (2025-01-01) -
Validation of hyperthermia as an enhancer of chemotherapeutic efficacy: insights from a bladder cancer organoid model
by: Ying Xu, et al.
Published: (2024-12-01) -
Epithelial cell diversity and immune remodeling in bladder cancer progression: insights from single-cell transcriptomics
by: Jianpeng Li, et al.
Published: (2025-01-01) -
Survey on ring signature
by: ZHANG Guo-yin, et al.
Published: (2007-01-01) -
Fatty acid metabolism-related signature suggests an oncogenic role of TEKT1 in endometrial cancer
by: Zhikai Xiahou, et al.
Published: (2025-01-01)